We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Researchers are investigating whether being right handed is due to genetics or other factors.

By MedImaging International staff writers
Posted on 03 Nov 2008
Print article
A multidisciplinary team of researchers is evaluating whether tissue optical spectroscopy can be utilized for early cancer detection in the pancreas during minimally invasive endoscopic diagnostic procedures.

Their objective is to help physicians distinguish between cancerous tissue transformations and benign changes in tissues due to different diseases, such as pancreatitis. Doing this can speed an accurate diagnosis and treatment to generate better patient outcomes. Pancreatic cancer is the fourth leading cause of cancer death in the United States alone; 95% of all patients diagnosed with the disease will die from it, more than half within six months of diagnosis.

"Until better treatment approaches can be developed, the only opportunity to change disease-associated mortality in pancreatic cancer patients is earlier diagnosis,” explained Mary-Ann Mycek, associate professor and associate chair of the University of Michigan (Ann Arbor, USA), department of biomedical engineering. "Current diagnostic methods have not been able to provide accurate diagnoses in early stages of the disease.”

The Michigan team's goal is to develop an optical technique to detect pancreatic cancer in patients at early stages--a development that could greatly improve the chances of patient survival by meeting the critical, unmet need of accurately differentiating malignant masses from benign pancreatitis. Such improved diagnostic accuracy could also appropriately triage patients, thereby preventing those without cancer from having unnecessary surgery.

To accomplish this, investigators used a multimodal optical spectroscopy approach based on observing reflectance and fluorescence properties of pancreatic tissue samples. Spectral analysis showed significant differences between normal, pancreatitis (inflammation), and cancerous tissues, thus suggesting noninvasive diagnostic possibilities for distinguishing among disease states.

The theory behind optically based diagnostics is this: in the body, the presence of disease alters tissue properties, such as local biochemistry and structure. Optically based disease diagnostic techniques can probe microscopic tissue alterations for signatures of disease, thereby leading to noninvasive diagnostics in living patients. Once detected optically, such diseased tissue may be treated. Because optical techniques do not require the removal of tissue, they could represent an advance in patient care over the invasive practice of tissue biopsy.

The study's findings were presented at Frontiers in Optics 2008 (FiO), the 92nd annual meeting of the Optical Society (OSA), which was held October 19-23, 2008, in Rochester, NY, USA.

Related Links:
University of Michigan


Radiation Shielding
Oversize Thyroid Shield
Portable Color Doppler Ultrasound System
S5000
Computed Tomography System
Aquilion ONE / INSIGHT Edition
X-ray Diagnostic System
FDX Visionary-A

Print article

Channels

MRI

view channel
Image: The AI tool can help interpret and assess how well treatments are working for MS patients (Photo courtesy of Shutterstock)

AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans

Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.